ArticleMedicine2026
Physical activity and type 2 diabetes risk: Heterogeneity in the dose-response by obesity and age.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical evidence increasingly identifies individuals with severe mental disorders as a population exhibiting markedly elevated susceptibility to diabetes and its associated complications. Within this context, physical inactivity and prolonged sedentary behavior emerge as prominent, modifiable risk factors contributing to type 2 diabetes mellitus (T2DM). However, a critical gap persists regarding whether obesity and age significantly modify the protective association of physical activity (PA) and T2DM, and the precise nature of this dose-response relationship remains inadequately characterized. We analyzed cross-sectional data from 5042 adult participants in the 2017-2020 National Health and Nutrition Examination Survey (NHANES). We applied weighted multivariable logistic regression models to evaluate the PA-T2DM association. Furthermore, to delineate the dose-response relationship, we utilized restricted cubic splines (RCS), specifically testing for potential effect modification by body mass index (BMI) and age. After comprehensive adjustment for confounders, our analysis indicated that higher PA levels were independently correlated with a reduced T2DM risk. RCS dose-response analysis revealed nuanced effect modification patterns. Specifically, PA's protective effect demonstrated a clear "BMI gradient" - most pronounced in normal-weight individuals, somewhat attenuated in the overweight group, and absent in participants with obesity. Concurrently, an "age stratification" pattern emerged; the association was strongest in middle-aged adults, exhibited a borderline significant trend among younger adults, and showed no significant association in older adults. Our findings suggest that the protective effect of PA against T2DM is modified by obesity and age. Consequently, future preventive strategies should evolve from universal PA recommendations toward more precise, stratified guidance that incorporates individual BMI and age profiles. This approach appears particularly relevant for integrated care models targeting high-risk populations, such as individuals with mental disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.